Joseph Lopes, MD
Urology · Oakland, MENPI 1093806200
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $295 of the $366 with a category attached, or 80.7%. It is spread thinly across 9 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $122 and has fallen 71.3% since, to $35 in 2025. That places this record below the midpoint for urology clinicians in ME, where the typical reported total is $1,024.
Across 15 payments — averaging $24.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$80
- Dentsply IH AB$55
- Coloplast$44
- Urogen Pharma, Inc.$42
- Endo Pharmaceuticals Inc.$38
- AstraZeneca$35
- plus $71 from 3 others
What the payments were for
- Food & beverage$29581%
- Education$7119%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $80 |
| Dentsply IH AB | 2 | $55 |
| Coloplast | 2 | $44 |
| Urogen Pharma, Inc. | 1 | $42 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca | 1 | $35 |
| Tolmar, Inc. | 1 | $28 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$366 in reported general payments places this provider in the 25th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 95 | $66,802 |
| GemtesaVibegron | 21 | $15,689 |
| Oxybutynin Chloride ErOxybutynin Chloride | 230 | $3,874 |
| Tamsulosin Hcl | 270 | $3,401 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $1,351 |
| Finasteride | 72 | $984 |
| Desmopressin Acetate | 12 | $530 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 19 | $358 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $197 |
| Sildenafil Citrate | 12 | $11 |
| Levofloxacin | 18 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $15,68921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 59 urology providers in Maine.
Other urology in Oakland
- Griffith BatstoneFarmington$123K
- David SobelPortland$58K
- Marc HodroffPortland$17K
- Evan DunnLewiston$9K
- Robert FisherRockport$9K
- Christopher HenryLewiston$6K
- Jesse SammonSouth Portland$6K
- Sanchita BoseSouth Portland$6K
- Michael ParkerLewiston$4K
- Michelle RamirezBiddeford$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.